Bridget Parsons is a market access leader with a background in clinical research, medical devices, and molecular diagnostics. She specializes in reimbursement strategy, payer policy, and evidence generation, helping laboratories and healthcare organizations navigate the evolving landscape of diagnostic testing. In her current role at DiaSorin, Bridget partners with commercial, medical, and health economics teams to develop market access strategies for innovative molecular diagnostic solutions. She is passionate about translating complex reimbursement and policy challenges into practical strategies that improve patient access to high-value diagnostic testing.